IRCT20090613002027N18招募中2 期
Comparison of efficacy and safety of timolol gel versus placebo in wound healing of patients with split-thickness skin grafts
Sari University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Age =18 years of age
- •Undergoing a procedure which results in the need of a STSG
- •Willing to provide written informed consent
排除标准
- •Pregnant women and breastfeeding
- •Use of systemic beta blockers drugs or topical except timolol
- •Hypersensitivity to timolol or other beta blockers
- •Severe, uncontrolled systemic comorbidities, such as diabetes, asthma, Chronic obstructive pulmonary disease
- •Use of systemic drugs that can impede wound healing, such retinoids or immune-suppressive drugs
- •Severe coagulation disorders including a lack of coagulation factors and immunologic thrombocytopenic purpura
研究者
相似试验
招募中
3 期
The efficacy and safety of 0.5% topical timolol on corneometry and transepidermal water loss after ablative fractional CO2 laser for atrophic acne scars: a split face randomized double blind placebo-controlled trialWe considered that timolol may have an effect in wound healing promotion in patients who undergo AFCO2 resurfacing. Our study aimed to investigate the efficacy and safety of 0.5% topical timolol maleaTCTR20190722005none25
招募中
2 期
Evaluation of efficacy of Topical Timolol for treatment in conjunctival Pyogenic GranulomPyogenic granuloma.Pyogenic granulomaL98.0IRCT20160523028008N27Hamedan University of Medical Sciences46
已完成
4 期
Treatment of Superficial Infantile Haemangiomas with Timolol and PropranololCTRI/2021/05/033307Varun Gupta40
尚未招募
4 期
sefulness of Timolol in a condition of vascular overgrowth of tissueCTRI/2019/04/018581Indian Association of Dermatologists Venereologists and Leprologists Research grant
尚未招募
4 期
A Trial to compare the effect of two drug combinations Tolperisone with Etodolac and Thiocolchicoside with Etodolac in patients with low back pain and muscle spasmCTRI/2012/11/003159one200